FDA Clears GE HealthCare's AI Auto-Contouring Software for Radiation Oncology
GE HealthCare received FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, software that automates contouring in radiation therapy planning. The clearance includes approval for a brain MRI model and an updated male pelvis CT model.
The software addresses a bottleneck in cancer treatment. Manual contouring-the process of mapping tumor boundaries and organs on imaging scans-consumes significant planning time before radiation therapy can begin.
How It Works
Unlike traditional auto-contouring tools, ProtégéAI+ 2.0 requires minimal manual input. It automatically processes CT and MR images, then exports results directly into treatment planning systems or other MIM workflows.
The underlying AI models were trained and validated across multiple institutions. Testing showed contour quality comparable to or better than manual approaches, according to company documentation.
What Changes for Clinicians
Reducing contouring time frees radiation oncology teams to focus on treatment plan refinement tailored to individual patients. This matters because radiation therapy is used in nearly 60% of cancer cases and treats over 2 million U.S. patients annually.
The FDA clearance includes a Predetermined Change Control Plan (PCCP). This framework allows GE HealthCare to introduce new anatomical models and imaging modalities without seeking separate FDA approvals for each update.
The Broader Context
Cancer kills nearly 10 million people worldwide each year, according to the World Health Organization. Earlier detection and faster treatment could reduce this burden, making efficiency gains in therapy planning clinically meaningful.
The software integrates into existing clinical workflows rather than requiring system overhauls. It's part of GE HealthCare's radiation oncology product portfolio.
For healthcare professionals managing treatment timelines and staff workload, this type of automation addresses a documented pain point. The question for individual institutions becomes whether the technology performs consistently in their specific patient populations and imaging equipment.
Learn more about AI for Healthcare and AI Agents & Automation in clinical settings.
Your membership also unlocks:
